A honey energy product is being recalled for containing an undeclared ingredient used for erectile dysfunction treatment.
In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...
IBSA USA, the U.S. subsidiary of the Swiss pharmaceutical company IBSA, announced today that the Food and Drug Administration ...
FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...
The Food and Drug Administration has approved Vybrique (sildenafil) oral film for the treatment of erectile dysfunction.
The Food and Drug Administration recalled a honey energy supplement on Wednesday after an undeclared erectile dysfunction ...
The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...
You don’t need to take it with water.
An informational overview examining category context, publicly available service disclosures, and what consumers often ...
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has secured a US notice of allowance for a continuation patent covering its ...
The Food and Drug Administration recalled a honey energy supplement on Wednesday after an undeclared erectile dysfunction ...
8d
Laser therapy eradicates prostate cancer in 84% of patients – without ‘causing erectile dysfunction’
A CUTTING-EDGE cold laser therapy could effectively treat prostate cancer and slash the risk of any debilitating side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results